 have a promising drug but when they come in you say oh sorry you have to start over again who does that really help it might make somebody feel good that they were so strong and so forth but actually it isn't the right way you really the fda needs to work with the companies figure out how the drug should be evaluated to see what its performance characteristics are and if they meet the standards